Navigation Links
Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs
Date:8/5/2011

LAS VEGAS, Aug. 5, 2011 /PRNewswire/ -- Jury selection in the second trial in the largest hepatitis C outbreak in U.S. history has begun in Clark County, Nevada. The Nevada Supreme Court lifted the stay allowing the case to go to trial when it was determined by the court that nurse David Hambrick, a witness for the defense Teva Inc. and Baxter Inc., "does not possess the requisite skill, knowledge or experience to testify as an expert witness regarding the medical cause of hepatitis C transmission at the Endoscopy Clinic of Southern Nevada," and that the defendants must have qualified, competent expert testimony given to a reasonable degree of medical probability for their alternative causation theory. 

(Photo:  http://photos.prnewswire.com/prnh/20110805/LA48404)

Plaintiff Anne Arnold was exposed to the virus hepatitis C when a contaminated jumbo 50mL infusion vial of the anesthesia medication Propofol was reused during a colonoscopy procedure at the Endoscopy Center of Southern Nevada on July 13, 2007. 50mL infusion vials of Propofol are meant for long tern sedation of patients, not short outpatient procedures like colonoscopies. Arnold was later diagnosed as having contracted hepatitis C. The lawsuit filed by Mainor Eglet alleges design defect, breach of implied warranty for a particular purpose, failure to properly warn by sending a Dear Health Care Professional letter and duty to monitor. 

In the complaint filed in Clark County District Court by Mainor Eglet Law Firm attorneys Robert Eglet, Robert Adams and Artemus Ham on behalf of plaintiffs Anne Arnold and spouse James Arnold -- the defendants Teva Parenteral Medicines, Inc.; SICOR Inc. and Baxter Healthcare Corporation -- are each responsible in some manner for causing injury and damages to the plaintiffs.  

"There are two primary issues in the Arnold case: th
'/>"/>

SOURCE Mainor Eglet Law Firm
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
2. China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23
3. QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer
4. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2011 and Provides Update on Development Activities
5. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
6. HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010
7. Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Isis Reports Financial Results and Highlights for Second Quarter 2011
9. DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
10. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
11. Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , a ... announced today that T. (Teo) Forcht Dagi , ... company,s Board of Directors. " Teo Forcht ... in neurosurgery, medical innovation and venture capital," said Remis ... delighted to add his clinical, strategic, and entrepreneurial expertise to ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... DUBLIN , August 29, 2014 ... management and collaboration software has announced a major new ... services, founded by renowned pathology expert, Dr. Marius ... advance of the 26th European Congress of Pathology which ... in the ExCeL Arena, London ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... April 14, 2011 Reportlinker.com announces that a new ... Neuropathy Therapy Area Pipeline Report ... Area Pipeline Report contains detailed information on the neuropathy ... status of neuropathy drugs by company and by stage ...
... 14, 2011 Reportlinker.com announces that a new ... Juvenile Rheumatoid Arthritis (JRA) Therapeutics ... http://www.reportlinker.com/p0479828/Juvenile-Rheumatoid-Arthritis-JRA-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... and Market Forecasts to 2017 ...
Cached Medicine Technology:Reportlinker Adds Neuropathy Therapy Area Pipeline Report 2Reportlinker Adds Neuropathy Therapy Area Pipeline Report 3Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8
(Date:8/29/2014)... August 29, 2014 Healthpointe is proud ... Rodas. Dr. Rodas will be practicing out of Healthpointe’s ... a member of Healthpointe’s orthopedic team, Dr. ... medicine, and board-certified in occupational medicine. , Among ... as Medical Director of Raytheon, the world-class defense and ...
(Date:8/29/2014)... La Miraca, California (PRWEB) August 29, 2014 ... clinical training to Chapman University Physical Therapy students ... students at Chapman University will be shadowing Healthpointe ... which will allow them to develop clinical experience ... University Physical Therapy students will gain insight into ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Pursuing its ... is set to unveil a stunning new design that ... company figures, the highly notable surrogacy platform has witnessed ... With over 13,000 visitors a month, the FindSurrogateMother.com community ... working toward one common goal — the precious gift ...
(Date:8/29/2014)... based on administering antidepressants for acute and chronic ... are needed to determine whether these drugs should ... basis., Dr. Ian Gilron, a professor and director ... Anesthesiology, and his team of seven researchers reviewed ... antidepressants for pain relief post-surgery would work more ...
(Date:8/29/2014)... Elk Grove Village, IL (PRWEB) August 29, 2014 ... an innovator in hearing wellness solutions, is on its ... Sept. 15-17 at the San Diego Convention Center to ... for those who work in high-noise industrial environments. Etymotic’s ... among the hottest wearable technology devices at the show. ...
Breaking Medicine News(10 mins):Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Antidepressants show potential for postoperative pain 2Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2
... 17 (HealthDay News) -- It,s normal and healthy for ... housing assistance, according to a new study. The ... involves slacker young adults who refuse to grow up ... children,s development, said the researchers. They analyzed data ...
... cartilage implants created using stem cells can only be ... measure before the almost inevitable need for total joint ... are investigating the possibilities of a biologically-engineered synthetic liquid ... by offering a one stop, permanent solution. ...
... Many Baby Boomers will experience a bone fracture as they ... to provide the necessary care required, according to a special ... Orthopaedic Surgery and Rehabilitation (GOS), published by SAGE. ... Baby Boom generation will reach 65 years old this year. ...
... WHAT: ... improve lung function and quality of life in individuals living with ... new study sponsored and conducted in part by the National Heart, ... "Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis," will ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) -- A ... the high doses that are typically used to treat acute ... study finds. Cytarabine is used in the treatment of ... stem cell transplantation. Cytarabine resembles a normal cell nutrient needed ...
... that while the number of visits to state parks across ... been significantly reduced. The reduction in funding during a time ... economic impact that state parks have on the nation,s economy. ... stress on America,s state-park systems," says Dr. Yu-Fai Leung, NC ...
Cached Medicine News:Health News:Young Adults May Need 'Safety Net' 2Health News:Liquid biomaterials take stem cell therapy to new level 2Health News:US healthcare system can't keep up with number of baby boomers' bone fractures 2Health News:Sirolimus therapy alleviates symptoms of lung disease LAM 2Health News:Less Is More With Acute Myeloid Leukemia Drug 2Health News:Study shows attendance at state parks grows, even as funding decreases 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: